Radiotherapy for glioblastoma in the elderly.

By F. Keime-Guibert, O. Chinot, L. Taillandier, S. Cartalat‐Carel, M. Frénay, G. Kantor, J. Guillamo, E. Jadaud, P. Colin, P. Bondiau and 9 more. New England Journal of Medicine, 2007

797 citations recorded by the source corpus.

Subfields: Genetics, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/4145663d8f3251c0159419ee91f55f0793bfa251

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. E. Corrales-García
2. P. Delgado-López

Citations in the corpus

• Survival in glioblastoma: a review on the impact of treatment modalities (2016, background): “The efficacy of radiotherapy on survival is rather modest for the elderly (over 70 years of age) with a median survival of 29 weeks, compared to 17 weeks in those who only received supportive care [63].”
• High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014, methodology): “8 Gy, 50 Gy) in patients >70 years of age was superior to best supportive care alone in a randomised phase III trial [II, B] [33].”
• Diffuse glioma growth: a guerilla war (2007, background): “oma patients, eradicating diVuse inWltrative glioma cells by radiotherapy without signiWcantly damaging the inWltrated brain parenchyma has been diYcult to achieve [80, 93, 95].”